Advertisement

Chronic Lymphocytic Leukemia

Disease State Hub

Featured

FDA Alert
FDA Alert
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
Poll
Poll
04/11/2024
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
04/11/2024
pop quiz
pop quiz
03/30/2024
Are you familiar with the patient populations most commonly diagnosed with chronic lymphocytic leukemia? Take this pop quiz to test your knowledge.
03/30/2024
Advertisement

Interactive Features

Poll
Poll
04/11/2024
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
04/11/2024
pop quiz
pop quiz
03/30/2024
Are you familiar with the patient populations most commonly diagnosed with chronic lymphocytic leukemia? Take this pop quiz to test your knowledge.
03/30/2024
Pop Quiz
Pop Quiz
02/27/2024
The American Cancer Society annually projects the number of new leukemia diagnoses in the United States. Which type of leukemia is projected to have the most diagnoses in 2024? Take the quiz to find out! ...
02/27/2024
Pop Quiz
Pop Quiz
02/12/2024
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
02/12/2024
Pop Quiz
Pop Quiz
04/11/2015
Risk factors may give a clinician an idea of the chance their patient has of developing a disease, like chronic lymphocytic leukemia (CLL). There are few known risk factors linked to CLL. Do you know which...
04/11/2015